1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMRC Impact Acceleration Awards is sponsored by Medical Research Council (MRC) / UKRI. Apply to the MRC Impact Acceleration Award to address a single, high-risk development step and generate key data to de-risk a new medicine, medical device, diagnostic, or other medical product.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Medical Research Council (MRC) – UKRI Medical Research Council (MRC) MRC funds world-leading discovery and translational research to accelerate diagnosis, advance treatment and prevent human illness.
Funding, assessment and award management Strategy, remit and programmes People, skills and fellowships Innovation and collaboration Investments, impacts and engagement Institutes, facilities and resources Video: we are the Medical Research Council World-first map of a male fly brain a win for neuroscience MRC funds world-class research into fatal genetic diseases First UK patient given bespoke lung cancer therapy vaccine Invite only: Precision prevention: biological mechanisms of response variation Apply for funding to study why people respond differently to biomedical prevention interventions.
Projects must generate mechanistic evidence in humans to provide insight into precision prevention through better targeting. You must be based at a UK research organisation eligible for MRC funding.
Medical Research Council (MRC) 10 September 2026 9:00am UK time 5 November 2026 4:00pm UK time Small molecule high throughput screen using AstraZeneca facilities Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots.
Medical Research Council (MRC) 10 September 2026 9:00am UK time 28 January 2027 4:00pm UK time View all MRC opportunities Medical Research Council (MRC) Funding, assessment and award management Strategy, remit and programmes People, skills and fellowships Innovation and collaboration Investments, impacts and engagement Institutes, facilities and resources Keep up to date with funding, news and events, and a weekly newsletter.
Webinar: experimental medicine to understand gambling disorder Public partnerships: Inside a successful MRC research application This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services .
According to the current listing, eligibility includes: Researchers based at a UK research organisation eligible for MRC funding. Projects must generate critical preliminary data to build confidence in the development strategy for a new medical intervention. Confirm the full requirements in the official notice before applying.
Applications for MRC Impact Acceleration Awards are due November 11, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
MRC Impact Acceleration Awards is funded by Medical Research Council (MRC) / UKRI. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read article